MTMT-ben szereplő publikációk tallózása szerző szerint "Zsákai, Lilian"

A találatok rendezése: Rendezés: Találatok:

  • Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing 
    H K Ho,; Németh, Gábor; Y R Ng,; E Pang,; C Szántai-Kis,; Zsákai, Lilian; Szokol, Bálint; Baska, Ferenc; Őrfi, László; Kéri, György (2013)
    Fibroblast growth factor receptor-4 (FGFR4) is a tyrosine kinase with a range of important physiological functions. However, it is also frequently mutated in various cancers and is now generating significant interest as a ...
  • Mycobacterium tuberculosis ellenes hatoanyagok fejlesztese es szerkezet-hatas osszefuggeseinek vizsgalata. 
    Baska, Ferenc; Szekely ER,; Szantai-Kis C,; Banhegyi P,; Hegymegi-Barakonyi, Bálint; Zsákai, Lilian; Kéri, György; Őrfi, László (2013)
    Tuberculosis is considered to be one of the major health problem not only in the less developed countries but in the economically developed countries as well. Roughly one third of the world's population are infected with ...
  • Potencialis antitumor hatasu FGFR inhibitorok fejlesztese. 
    Zsákai, Lilian; Nemeth G,; Szantai-Kis C,; Greff Z,; Horvath Z,; Szokol, Bálint; Baska, Ferenc; Őrfi, László; Kéri, György (2013)
    Fibroblast Growth Factor Receptor (FGFR) family is a sequentially highly related subgroup of membrane proteins consisting of four tyrosine kinase type enzyme: FGFR1, FGFR2, FGFR3 and FGFR4. These are kinases of great ...
  • SignaLink 2 - a signaling pathway resource with multi-layered regulatory networks 
    Fazekas D,; Koltai M,; Türei, Dénes; Módos, Dezső; Palfy M,; Dúl, Zoltán; Zsákai, Lilian; Földvári-Nagy Lászlóné Lenti, Katalin; Farkas, Illés; Vellai, Tibor; Csermely, Péter; Korcsmáros, Tamás (2013)
    ABSTRACT: BACKGROUND: Signaling networks in eukaryotes are made up of upstream and downstream subnetworks. The upstream subnetwork contains the intertwined network of signaling pathways, while the downstream regulatory ...